Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment

Journal: Science Advances

Published: 2019-07-01

DOI: 10.1126/sciadv.aav9019

Affiliations: 24

Authors: 23

Go to article
Institutions Share
Institute of Molecular Virology, Ulm University, Germany 0.14
University of Paris, France 0.12
Center for Translational Science (CRT), Pasteur Institute, France 0.06
Institut de Recherche en Infectiologie de Montpellier (IRIM), France 0.04
Institute for Clinical Transfusion Medicine and Immunogenetics (IKT), Germany 0.04
Robert Debré University Hospital, France 0.04
Computational Biochemistry Group, UDE, Germany 0.04
Centre for Medical Biotechnology (ZMB), UDE, Germany 0.04
Institute of Epidemiology and Medical Biometry, Ulm University, Germany 0.04
Toxicology Pharmacology and Cellular Signaling, France 0.04
Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques (LCBPT), France 0.04
Laboratory of Chemistry, Biology, Modelling and Immunology for Therapy (CBMIT), France 0.04
Imagine Institute, France 0.04
Hôpital Necker-Enfants Malades, France 0.04
Physiopathologie du Système Immunitaire, France 0.04
Laboratory of Immunobiology of Dendritic Cells, France 0.04
Immunopathologie et Chimie Thérapeutique, IBMC, France 0.03
University Hospitals of Strasbourg (HUS), France 0.03
Faculty of Medicine, University of Strasbourg, France 0.03
Institut Cochin, France 0.03
Immunologie - Hématologie et Rhumatologie Pédiatrique, Hôpital Necker-Enfants Malades, France 0.03
Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, France 0.01